Angelica Loskog
Net worth: 1 286 $ as of 31/08/2026
Net worth: 1 286 $ as of 31/08/2026
Angelica Loskog currently works at Lokon Pharma AB, as Chief Executive Officer & Director, Repos Pharma AB, as Chairman, Medivir AB, as Director from 2024, the University of Uppsala, as Associate Professor, and Nexttobe AB, as Scientific Adviser.
Dr. Loskog also formerly worked at Vivolux AB, as Chairman, Hansa Biopharma AB, as Independent Director from 2016 to 2019, and Bioimics AB, as Director.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/03/2026 | 6,309 ( 0% ) | 1 286 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| MEDIVIR AB | Director/Board Member | 01/01/2024 |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Chief Tech/Sci/R&D Officer | - |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Lokon Pharma AB
Lokon Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides immunostimulatory gene therapy services | Chief Executive Officer | - |
Repos Pharma AB | Chairman | - |
| Companies | Position | End |
|---|---|---|
| HANSA BIOPHARMA AB | Director/Board Member | 22/05/2019 |
Bioimics AB | Director/Board Member | - |
Vivolux AB
Vivolux AB BiotechnologyHealth Technology Develops biotechnology for anticancer drugs | Chairman | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Vivolux AB
Vivolux AB BiotechnologyHealth Technology Develops biotechnology for anticancer drugs | Health Technology |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Finance |
Bioimics AB | |
Lokon Pharma AB
Lokon Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides immunostimulatory gene therapy services | Commercial Services |
Repos Pharma AB |
Select your edition
All financial news and data tailored to specific country editions